GHK-Cu and tissue repair
Experimental studies have investigated GHK-Cu for fibroblast activity, extracellular-matrix production, and tissue-repair processes.
GLOW is a research peptide blend combining GHK-Cu, BPC-157, and TB-500. The individual peptides have been studied in preclinical research related to tissue repair, wound healing, cellular signaling, and recovery pathways. The complete blend has not been clinically validated.

Typical dose
1.4–2.8 mg
No established frequency
Route
Subcutaneous injection
No established timing
Cycle
4–8 weeks.
Typical duration
Storage
2–8°C
Follow vendor guidance
Marketplace
16 offers for GLOW Blend
| Vendor | Price | Rating | Shipping | COA | Action |
|---|---|---|---|---|---|
Reta One Labs
| $45.00 $0.64/mg | No reviews | 2 days United States | 1 file | |
Renova Peptides
| $49.00 $0.70/mg | No reviews | 3–5 days United States | 1 file | |
Amino Club
| $58.49 $89.99 $0.84/mg −35% | No reviews | 1–4 days United States | 1 file | |
Peptix USA
| $84.96 $90.00 $1.21/mg −5.6% | No reviews | 3–5 days United States | 1 file | |
HLX LABS
| $84.99 $124.99 $1.21/mg −32% | No reviews | 2–5 days United States | 1 file | |
Bionova Peptides
| $89.99 $1.29/mg | No reviews | 1–3 days United States | 1 file | |
LA Peptides
| $89.99 $1.29/mg | No reviews | 2–5 days United States | 1 file | |
prpeps
| $95.00 $1.36/mg | No reviews | 2 days United States | None |
What the research reports
GLOW combines GHK-Cu, BPC-157, and TB-500. Research on the individual components suggests potential roles in tissue repair, wound healing, cellular signaling, and recovery. The complete GLOW combination has not been clinically validated.
Tissue Repair
Wound Healing
Skin Health
Recovery Support
Dosage and protocol
There is no clinically established dosing protocol for the complete GLOW blend. Published research primarily evaluates the individual components rather than the commercial combination.
01 Route
Subcutaneous injection
02 Example range
No established human range
03 Frequency
No established frequency
04 Timing
No established timing
Educational reference only. Use clinician guidance for dosing decisions.
Evidence
Experimental studies have investigated GHK-Cu for fibroblast activity, extracellular-matrix production, and tissue-repair processes.
BPC-157 has shown tissue-protective and wound-healing effects in several animal and laboratory models, but robust human clinical evidence is lacking.
Thymosin β4 has been studied for cell migration, angiogenesis, and wound healing. TB-500 is related to thymosin β4 but should not automatically be considered equivalent to the native peptide.
No controlled clinical study has established the safety, efficacy, dosage, or cycle of the complete GLOW blend.
Interactions
Other peptide blends
No clinical interaction studies have established the safety of combining GLOW with other peptide blends
Anti-inflammatory drugs
Individual GLOW components have demonstrated biological effects related to inflammation, but clinically meaningful interactions with anti-inflammatory drugs have not been established.
Anticoagulants / antiplatelet drugs
No established human drug interaction has been demonstrated for the complete GLOW combination.
Copper supplements
GHK-Cu contains copper. The clinical significance of combining GHK-Cu-containing blends with copper supplementation has not been established.
FAQ
GLOW is a research peptide blend commonly containing GHK-Cu, BPC-157, and TB-500.